International Flavors & Fragrances Inc.
Key Drivers
- Strong gross margins
- Positive free cashflow
- High operating costs
AIAI Summary
IFF's strategic pivot to higher‑margin Health & Biosciences makes IFF a conditional, multi‑year recovery play—require 3–6 quarters of consistent EBITDA beats, rising organic growth, or meaningful divestiture proceeds to justify holding, because the primary downside is large intangibles/amortization and execution risk on margin/ROIC improvement.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong gross margins
- •Positive free cashflow
- •High operating costs
IFF generates strong cash flow and gross margins but remains loss-making due to high operating costs and a large intangible asset base, leaving valuation elevated despite moderate leverage.
Price Behavior
Key Price Behavior Insights:
- •Below MA
- •Sharp decline
- •Support $66–68
IFF is in a clear short-term downtrend—down ~17–18% over the last month, trading well below the ~$74.60 last-month moving average with near-term support around $66–68 and resistance near $81–82.
Sharp ~17–18% drop from $80.91 to $66.62 over the last month
Sentiment & News
Key News Insights:
- •Portfolio divestiture
- •Latin America expansion
- •Investor sell‑downs
IFF is reshaping its portfolio while investing in Latin America and sustainable products amid shareholder sell‑downs and a regulatory probe, leaving shares under pressure despite analyst optimism.
The mix of disposals, regional investment and regulatory scrutiny should pressure near‑term share sentiment but could stabilize if growth in Health & Biosciences offsets margin impacts
Similar Companies in Basic Materials
Other companies in the same sector with AI ratings